Literature DB >> 26870672

Neuropathology of JC virus infection in progressive multifocal leukoencephalopathy in remission.

Karen S SantaCruz1, Gulmohor Roy1, James Spigel1, Elaine L Bearer1.   

Abstract

AIM: To investigate the neuropathology of the brain in a rare case of remission following diagnosis of progressive multifocal leukoencephalopathy (PML).
METHODS: Consent from the family for an autopsy was obtained, clinical records and radiograms were retrieved. A complete autopsy was performed, with brain examination after fixation and coronal sectioning at 1 cm intervals. Fourteen regions were collected for paraffin embedding and staining for microscopic analysis. Histologic sections were stained with Luxol blue, hematoxylin/eosin, and immunostained for myelin basic protein, neurofilament, SV40 T antigen and p53. The biopsy material was also retrieved and sections were stained with hematoxylin/eosin and immunostained for SV40 and p53. Sections were examined by American Board of Pathology certified pathologists and images captured digitally.
RESULTS: Review of the clinical records was notable for a history of ulcerative colitis resulting in total colectomy in 1977 and a liver transplant in 1998 followed by immune-suppressive therapy. Neurological symptoms presented immediately, therefore a biopsy was obtained which was diagnosed as PML. Immunotherapy was adjusted and clinical improvement was noted. No subsequent progression was reported. Review of the biopsy demonstrated atypical astrocytes and enlarged hyperchromatic oligodendroglial cells consistent with JC virus infection. Strong SV40 and p53 staining was found in glial cells and regions of dense macrophage infiltration were present. On gross examination of the post-mortem brain, a lesion in the same site as the original biopsy in the cerebellum was identified but no other lesions in the brain were found. Microscopic analysis of this cerebellar lesion revealed a loss of myelin and axons, and evidence of axonal damage. This single burned-out lesion was equivocally positive for SV40 antigen with little p53 staining. Examination of thirteen other brain regions found no other occult sites.
CONCLUSION: Our study reveals residual damage, rare macrophages or other inflammation and minimal evidence of persistent virus. This case demonstrates the possibility of complete remission of PML.

Entities:  

Keywords:  Demyelinating; JC virus; Progressive multifocal leukoencephalopathy; Remission

Year:  2016        PMID: 26870672      PMCID: PMC4735552          DOI: 10.5501/wjv.v5.i1.31

Source DB:  PubMed          Journal:  World J Virol        ISSN: 2220-3249


  26 in total

Review 1.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.

Authors:  P N Jensen; E O Major
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 2.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

3.  Childhood case of progressive multifocal leukoencephalopathy with improved clinical outcome.

Authors:  Ercan Demir; Uwe G Liebert; Figen Söylemezoglu; Kalbiye Yalaz; Gülsen Köse; Banu Anlar
Journal:  J Child Neurol       Date:  2005-03       Impact factor: 1.987

4.  Multifocal leuko-encephalopathy with slow progression and very long survival.

Authors:  F C Stam
Journal:  Psychiatr Neurol Neurochir       Date:  1966 Nov-Dec

5.  Integration pattern of human JC virus sequences in two clones of a cell line established from a JC virus-induced hamster brain tumor.

Authors:  W S Wold; M Green; J K Mackey; J D Martin; B L Padgett; D L Walker
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

Review 6.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 7.  Progressive multifocal leukoencephalopathy: why gray and white matter.

Authors:  Sarah Gheuens; Christian Wüthrich; Igor J Koralnik
Journal:  Annu Rev Pathol       Date:  2012-10-18       Impact factor: 23.472

Review 8.  JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?

Authors:  Tatiana R Coelho; Luis Almeida; Pedro A Lazo
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

9.  JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.

Authors:  R A Du Pasquier; K W Clark; P S Smith; J T Joseph; J M Mazullo; U De Girolami; N L Letvin; I J Koralnik
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 3.739

Review 10.  Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus.

Authors:  Ruth F Itzhaki
Journal:  Front Aging Neurosci       Date:  2014-08-11       Impact factor: 5.750

View more
  4 in total

1.  Neuroimmune Regulation of JC Virus by Intracellular and Extracellular Agnoprotein.

Authors:  Michael Craigie; Stephanie Cicalese; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2017-11-20       Impact factor: 4.147

Review 2.  Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis.

Authors:  Luis Del Valle; Sergio Piña-Oviedo
Journal:  Front Oncol       Date:  2019-08-08       Impact factor: 6.244

3.  Evidence of Human Parvovirus B19 Infection in the Post-Mortem Brain Tissue of the Elderly.

Authors:  Sandra Skuja; Anda Vilmane; Simons Svirskis; Valerija Groma; Modra Murovska
Journal:  Viruses       Date:  2018-10-25       Impact factor: 5.048

Review 4.  Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair.

Authors:  Hernan Nicolas Lemus; Arthur E Warrington; Moses Rodriguez
Journal:  Neurol Clin       Date:  2018-02       Impact factor: 3.806

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.